Skip to content
Forensic Analysis · Pharmaceuticals & Biotechnology · as of Nov 8, 2026

Cns Pharmaceuticals, Inc. (CNSP)

A forensic read on Cns Pharmaceuticals, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution
Forensic grade
Distress
Financial health
-46.2
Distress distance
1
Forensic signals
-296.3%
ROE

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Cns Pharmaceuticals, Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -46.2, placing it in the Distress zone. 1 forensic signal was flagged in its latest SEC filings, led by share-count dilution.

What the filings flag

+1615.2%/yr
FY2023–FY2025
Share-count dilution. Diluted share count changed +29321% over the last 2 years to FY2025 (+1615.2%/yr). The count is growing — 0.0M shares in FY2023, 0.4M in FY2025: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~1615.2% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~100%.

Key fundamentals

Free Cash Flow-$13.8M
Return on Equity-296.3%
Debt / Equity0.07x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Cns Pharmaceuticals, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 8, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.